AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
3101
Tectonic Therapeutic
TECX
$601M
| $231K | ﹤0.01% |
+7,460
| New | +$219K |
|
|
BHR
3102
Braemar Hotels & Resorts
BHR
$130M
| $229K | ﹤0.01% |
96,950
+13,400
| +16% | +$32.1K |
|
3103
Mistras Group
MG
$609M
| $229K | ﹤0.01% |
15,480
+3,600
| +30% | +$64.1K |
|
|
RNA
3104
Atrium Therapeutics
RNA
$243M
| $229K | ﹤0.01% |
17,110
+4,140
| +32% | +$54.1K |
|
|
LAC
3105
Lithium Americas
LAC
$1.09B
| $227K | ﹤0.01% |
57,542
+44,460
| +340% | +$212K |
|
3106
Intercorp Financial Services
IFS
$6.15B
| $227K | ﹤0.01% |
+3,981
| New | +$197K |
|
3107
Telos
TLS
$359M
| $225K | ﹤0.01% |
53,770
+10,491
| +24% | +$46.4K |
|
3108
Repay Holdings
RPAY
$322M
| $225K | ﹤0.01% |
86,400
+11,000
| +15% | +$38.2K |
|
3109
iShares Global Comm Services ETF
IXP
$461M
| $222K | ﹤0.01% |
1,932
| – | – |
|
3110
CVRx
CVRX
$81.3M
| $221K | ﹤0.01% |
23,360
+5,800
| +33% | +$37.4K |
|
|
STLN
3111
Starling Oncology
STLN
$604M
| $219K | ﹤0.01% |
71,400
+9,800
| +16% | +$41.2K |
|
3112
CS Disco
LAW
$275M
| $218K | ﹤0.01% |
57,040
| – | – |
|
|
CNL
3113
Collective Mining Ltd
CNL
$1.55B
| $217K | ﹤0.01% |
12,340
| – | – |
|
3114
SES AI
SES
$187M
| $217K | ﹤0.01% |
+225,800
| New | +$246K |
|
|
CLYM
3115
Climb Bio
CLYM
$891M
| $217K | ﹤0.01% |
+31,670
| New | +$327K |
|
|
VNET
3116
VNET Group
VNET
$1.81B
| $215K | ﹤0.01% |
25,665
| – | – |
|
3117
Abeona Therapeutics
ABEO
$343M
| $215K | ﹤0.01% |
47,950
+30,030
| +168% | +$165K |
|
3118
Plumas Bancorp
PLBC
$440M
| $215K | ﹤0.01% |
+4,400
| New | +$233K |
|
3119
Acco Brands
ACCO
$408M
| $215K | ﹤0.01% |
71,586
+16,860
| +31% | +$61.9K |
|
3120
Neumora Therapeutics
NMRA
$246M
| $215K | ﹤0.01% |
+110,100
| New | +$210K |
|
3121
Tucows
TCX
$120M
| $214K | ﹤0.01% |
12,490
+300
| +2% | +$4.55K |
|
3122
Aclaris Therapeutics
ACRS
$908M
| $214K | ﹤0.01% |
57,000
+41,800
| +275% | +$186K |
|
3123
Shattuck Labs
STTK
$681M
| $213K | ﹤0.01% |
+33,190
| New | +$207K |
|
3124
Nkarta
NKTX
$209M
| $213K | ﹤0.01% |
100,950
+11,080
| +12% | +$31.2K |
|
|
WBTN
3125
WEBTOON Entertainment Inc
WBTN
$1.35B
| $210K | ﹤0.01% |
22,900
+7,300
| +47% | +$86.4K |
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.